St. Charles, Missouri Clinical Trials

*Healthy Patient Studies

Pharma Medica Research, INC

Pharma Medica Research, INC is seeking Healthy participants for a research study.

Pharma Medica Research, INC

Healthy, Post-Menopausal Females

Attention Deficit/Hyperactivity Disorder (ADHD - Adults)

Midwest Research Group

A clinical trial seeking patients for a research study for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Midwest Research Group

A Phase 3 clinical study for patients with Adult Attention Hyperactivity Disorder

Midwest Research Group Updated

Patients are needed to participate in a clinical research study of SHP465 and Placebo to evaluate Attention-Deficit Hyperactivity Disorder (ADHD)

Autism

St. Charles Psychiatric Associates

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Bipolar Disorder

Takeda Study Site Updated

Clinical trial for Bipolar I

Chronic Obstructive Lung Disease

Midwest Chest Consultants, PC

A Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Monderate

COPD (Chronic Obstructive Pulmonary Disease)

Midwest Chest Consultants, PC

A Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Monderate

Midwest Chest Consultants, PC

A Phase III, 52-week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease.

Midwest Chest Consultants, PC

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD).

View More »

1237.19.10101 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease

Forest Investigative Site 2413

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

GSK Investigational Site Updated

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site Updated

A clinical trial to evaluate treatments using UMEC/VI DPI, Placebo DPI and Albuterol/salbutamol MDI for patients with Pulmonary Disease, Chronic Obstructive

GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Midwest Chest Consultants PC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Midwest Chest Consultants, P.C.

Patients are needed to participate in a clinical research study of SUN101 and Placebo to evaluate COPD

Pearl Investigative Site

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Depression

St. Charles Psychiatric Associates/Midwest Research Group

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

View More »

Alkermes Investigational Site

A clinical trial seeking patients for a research study for the treatment of Major Depressive Disorder (MDD)

Forest Investigative Site 040

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Forest Investigative Site 055

A Phase 3 clinical study for patients with Major Depressive Disorder

St. Charles Psychiatric Associates

A Phase 3 clinical study for patients with Bipolar I Depression

Depression (Adult and Geriatric)

St. Charles Psychiatric Associates/Midwest Research Group

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Depression (Treatment-Resistant)

St. Charles Psychiatric Associates/Midwest Research Group

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Kidney Disease

St. Joseph Medical Center

A clinical trial seeking patients for a research study for the treatment of Contrast Induced Nephropathy

Lung Disease

1237.19.10101 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease

GSK Investigational Site Updated

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

GSK Investigational Site Updated

A clinical trial to evaluate treatments using UMEC/VI DPI, Placebo DPI and Albuterol/salbutamol MDI for patients with Pulmonary Disease, Chronic Obstructive

Midwest Chest Consultants PC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Schizophrenia and Schizoaffective Disorders

Research Site

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Centerpointe Hospital

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

St. Charles Psychiatric Associates

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Stroke

Research Site

A Phase 3 clinical study for patients with Cardiovascular Disease